Neurofibromatosis versus schwannomatosis;Neurofibromatose versus schwannomatose

Fortschritte der Neurologie Psychiatrie

Volumn 66, Issue 6, 1998, Pages 271-277

  Mautner, V F ^a   Schroder S ^b   Pulst, S M ^c   Ostertag, H ^d   Lkiuwe, ^b,e  

^a Albertinen Krankenhauses Hamburg   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c CEDARS SINAI MEDICAL CENTER   (United States)

^d NORDSTADT HOSPITAL   (Germany)

^e Neurologische Abt Klinikum Nord   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CAFE AU LAIT SPOT; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE CLASSIFICATION; FEMALE; GENE EXPRESSION; GENE MUTATION; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; NEURILEMOMA; NEUROFIBROMATOSIS;

EID: 0031776013     PISSN: 07204299     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-995262     Document Type: Article

References (27)

1. Barker, D., E. Wright, K. Nguyen et al. Gene for von Recklinghausen neurofibromatosis is in the pericentromeric region ofchromosom 17. Science 236 (1987) 1100-1102
2. Daras, A., B. S. Koppel. C. W. Heise. M. J. Maezzo, T. P. Poon, K. R. Duffy Multiple spinal intradural schwannomas in the absence of Von Recklinghausen disease. Spine 18 (1993) 2556-2559
3. Evans, D. G. R., S. Mason, S. M. Huson Spinal and cutaneous schwannomatosis is a variant form of type 2 neurofibromatosis a clinical and molecular study. J. Neurol. Neurosurg. Psychiatry 62(1997) 361-366
4. Gutman, D. H., A. Aylsworth, J. C. Carey, B. Korf, J. Marks, R. E. Pyeritz, A. Rubenstein, D. Viskochil The diagnostic evaluation and multidisciplinary management of neurofibromatosis type 1 and 2.-JAMA 278 (1997) 51 -57
5. Halliday, A. L, R. A. Sobel, R. L Martuza Benign spinal nerve sheat tumors their occurence sporadically and in neurofibromatosis types 1 and 2.J. Neurosurg. 74 (1991) 248-250
6. Huson, S. M., P. S. Haper, D. A. S. Compston Von Recklinghausen neurofibromatosis a clinical and population study in South East Wales. Brain 111 (1988) 1355-1381
7. Huynh, D., T. Nechiporuk, S. M. Pulst Alternative transcripts in the mouse neurofibromatosis type 2 (NF2) gene area conserved and code for schwannomas with distinct C-terminal domains. Hum. Mol. Genet. 3 (7) (1994) 1075-1079
8. Jacoby, L B., D.Jones. K. Davis, D. Kronn, M. P. Short, J. Gusella. M. MacCollin Molecular analysis of the NF2 Tumor Suppressor in Schwannomatosis. Am. J. Hum. Genetics im Druck
9. Kluwe. L. S. Bayer, M. E. Baser, W. Hazim, W. Haase, C. Fünsterer, V. F. Mautner Identification of NF2 germline mutations and comparison with neurofibromatosis 2 phenotypes. Hum. Genet. 98 (1996) 534-538
10. Kluwe, L, S. M. Pulst, J. Koppen, V. F. Mautner A 163-bp deletion in the neurofibromatosis 2 (NF2) gene associated with variant phenotypes. Hum. Genet. 95 (1995) 443-444
11. Lindenau. M., L Kluwe, V. F. Mautner Neurologische Defizite durch spinale Raumforderungen bei Neurofibromatose Typ 2. Abstrakt IV.Jahrestagung der von Recklinghausen-Gesellschaft, Hamburg 1996
12. Lutchman. M., G. A. Rouleau The neurofibromatosis type 2 gene product schwannomin suppresses Growth of NIH 3T3 cells. Cancer Res. 55 (11) (1995) 2270-2274
13. MacCollin, M., W. Woodfin, D. Kronn, M. P. Short Schwannomatosis. A clinical and pathologic study. Neurology 46 (1996) 1072-1079
14. Mautner, V. F., M. Lindenau, J. Koppen, W. Hazim, L Kluwe Neurofibromatose Typ 2 ohne Akustikusneurinome. Zentralblatt Neurochir. (1995) 5683-5687
15. Mautner, V. F., S. M. Pulst Nicht klassifizierbare Neurofibromatose. Akt. Neurol. 20 (1993) 123-127
16. Mautner, V. F., M. Tatagiba, M. Lindenau, C. Fünsterer, S. M. Pulst. L Kluwe, F. E. Zanella Spinal Tumors in Patients with Neurofibromatosis Type 2 MR Imaging Study of Frequency, Multiplicity and Variety. Am. J. Roentgenology 165 (1995) 951 -955
17. Mautner, V. F., M. Lindenau, M. E. Baser. L Kluwe, J. Gottschalk Skin abnormalities in neurofibromatosis 2. Arch, of Dermatology /VOL 133, Dec 1997
18. Merel, P., K. Hoang-Xuan, M. Sanson et al. Screening for GermLine mutations in the NF2 Gene. Genes Chrom. Cancer 12 (1995) 117-127
19. National Institutes of Health Consensus Development Conference Statement on Acoustic Neuroma, December 11-13,1991. The Consensus Development Panel. Arch. Neurol. 51 (2) (1994) 201-207
20. Pulst, S. M., V. M. Riccardi, M. Ren et al. Spinal neurofibromatosis is linked to the neurofibromatosis 1 region on chromosome 17. Am. J. Hum. Genet. 45 (1989) A615
21. Purcell. S. M., S. L Dixon Schwannomatosis an unusual variant of neurofibromatosis or a distinct clinical disorder. Arch. Dermatol. 125 (3) (1989) 390-393
22. Riccardi, V. M., J. E. Eichner Neurofibromatosis phenotype, natural history and pathogenesis. 2nd edn. John Hopkins University Press, Baltimore, London 1992
23. Rouleau, G. A., P. Merel, M. Luchtmann et al. Alteration in a new gene encoding a putative membrane-organizing protein causes neurofibromatosis type 2. Nature 363 (1993) 515-521
24. Sainz, J., D. P. Huynh, K. Figuera, N. K. Ragge, M. E. Baser, S. M. Pulst Mutations of the neurofibromatosis type 2 gene and lack of the gene product in vestibular schwannomas. Hum. Mol. Genet. 3 (6) (1994) 885-891
25. Thakkar, S. D., V. F. Mautner Spinal tumors in patients with neurofibromatosis type 1. Abstrakt, IV.Jahrestagung der von Recklinghausen-Gesellschaft e.V., Hamburg 1996
26. Theiler. R., H. Stocker, E. Boltshauser Zur Klassifizierung atypischer Neurofibromatose-Formen. Schweiz, med. Wschr. 121 (1991) 446-455
27. Tikoo, M., M. Varga, V. Ramesh, J. Gusella, H. Maruta An Anti-Ras function of neurofibromatosis type 2 gene product (NF2/Merlin). J. Biol. Chem. 269 (38) (1994) 2387-2390